Condition
Low Testosterone
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results75% success
Data Visualizations
Phase Distribution
5Total
P 1 (1)
P 2 (3)
P 4 (1)
Trial Status
Completed3
Terminated1
Withdrawn1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04975334Phase 1Completed
Opioid Antagonism in Hypogonadotropic Hypogonadism
NCT00163566Phase 2Completed
Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80
NCT02381288Phase 2TerminatedPrimary
Effects of TAK-448 in Middle-aged and Older Men With Low Testosterone
NCT01689896Phase 4WithdrawnPrimary
Testosterone and Pain Sensitivity
NCT01386567Phase 2Completed
A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA-203
Showing all 5 trials